{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:19:33Z","timestamp":1785161973588,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,26]]},"DOI":"10.7759\/cureus.61135","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T22:38:26Z","timestamp":1716763106000},"source":"Crossref","is-referenced-by-count":2,"title":["Aplastic Anemia With Thrombosis Following the Administration of Immunosuppressant and Thrombopoietin Receptor Agonist (TPO-RA)"],"prefix":"10.7759","author":[{"given":"Tadafumi","family":"Iino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes MJ","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, et al.. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012, 367:11-9. 10.1056\/NEJMoa1200931","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour R","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al.. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022, 386:11-23. 10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.09.006","article-title":"Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist","volume":"33","author":"Erickson-Miller CL","year":"2005","unstructured":"Erickson-Miller CL, DeLorme E, Tian SS, et al.. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist. Exp Hematol. 2005, 33:85-93. 10.1016\/j.exphem.2004.09.006","journal-title":"Exp Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2015.03.014","article-title":"Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Catal\u00e1-L\u00f3pez F","year":"2015","unstructured":"Catal\u00e1-L\u00f3pez F, Corrales I, de la Fuente-Honrubia C, Gonz\u00e1lez-Bermejo D, Mart\u00edn-Serrano G, Montero D, Saint-Gerons DM. Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials. Med Clin (Barc). 2015, 145:511-9. 10.1016\/j.medcli.2015.03.014","journal-title":"Med Clin (Barc)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj A","year":"2024","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, et al.. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline. Br J Haematol. 2024, 204:784-804. 10.1111\/bjh.19236","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-393900","article-title":"In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation","volume":"119","author":"Psaila B","year":"2012","unstructured":"Psaila B, Bussel JB, Linden MD, et al.. In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood. 2012, 119:4066-72. 10.1182\/blood-2011-11-393900","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1249-5","article-title":"Platelet activation and function during eltrombopag treatment in immune thrombocytopenia","volume":"91","author":"Haselboeck J","year":"2012","unstructured":"Haselboeck J, Pabinger I, Ay C, Koder S, Koder S, Panzer S. Platelet activation and function during eltrombopag treatment in immune thrombocytopenia. Ann Hematol. 2012, 91:109-13. 10.1007\/s00277-011-1249-5","journal-title":"Ann Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V7.9.942.942","article-title":"Case report: aplastic anemia with platelet thrombi","volume":"7","author":"Frumin AM","year":"1952","unstructured":"Frumin AM, Conston AS, Meranze DR. Case report: aplastic anemia with platelet thrombi. Blood. 1952, 7:942-7. 10.1182\/blood.V7.9.942.942","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.35.369","article-title":"Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids","volume":"35","author":"Toyama M","year":"1994","unstructured":"Toyama M, Watanabe S, Kobayashi T, Iida K, Koseki S, Yamaguchi I, Sugishita Y. Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids. Jpn Heart J. 1994, 35:369-73. 10.1536\/ihj.35.369","journal-title":"Jpn Heart J"},{"key":"ref10","article-title":"Thrombotic complication in the course of aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome; possible involvement of dysplasminogenemia (plasminogen Tochigi) in the pathogenesis of thrombosis. [Article in Japanese]","volume":"37","author":"Takahashi H","year":"1996","unstructured":"Takahashi H, Izumi T, Toshima M, et al.. Thrombotic complication in the course of aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome; possible involvement of dysplasminogenemia (plasminogen Tochigi) in the pathogenesis of thrombosis. [Article in Japanese]. Rinsho Ketsueki. 1996, 37:249-54.","journal-title":"Rinsho Ketsueki"},{"key":"ref11","article-title":"Development of cerebral venous sinus thrombosis in an aplastic anemia patient with antiphospholipid syndrome","volume":"123","author":"Chen JH","year":"2010","unstructured":"Chen JH, You X, Qian M. Development of cerebral venous sinus thrombosis in an aplastic anemia patient with antiphospholipid syndrome. Chin Med J (Engl). 2010, 123:2486-8.","journal-title":"Chin Med J (Engl)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.86556","article-title":"An uncommon site of dural tear in a case of spontaneous intracranial hypotention demonstrated using contrast enhanced magnetic resonance cisternography","volume":"59","author":"Bhat MD","year":"2011","unstructured":"Bhat MD, Prasad C, Pruthi N, Vasudev MK, Sharath Kumar GG. An uncommon site of dural tear in a case of spontaneous intracranial hypotention demonstrated using contrast enhanced magnetic resonance cisternography. Neurol India. 2011, 59:761-2. 10.4103\/0028-3886.86556","journal-title":"Neurol India"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2012.42.1.54","article-title":"A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia","volume":"42","author":"Shin HS","year":"2012","unstructured":"Shin HS, Kang TS. A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia. Korean Circ J. 2012, 42:54-7. 10.4070\/kcj.2012.42.1.54","journal-title":"Korean Circ J"},{"key":"ref14","article-title":"Paroxysmal nocturnal haemoglobinuria type III presenting as portal and mesenteric vein thrombosis in a young girl","volume":"26","author":"Sarwar S","year":"2016","unstructured":"Sarwar S, Chaudhry M, Ali N. Paroxysmal nocturnal haemoglobinuria type III presenting as portal and mesenteric vein thrombosis in a young girl. J Coll Physicians Surg Pak. 2016, 26:106-8.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011642","article-title":"Cyclosporin A-related cerebral venous sinus thrombosis: a case report","volume":"97","author":"Gao F","year":"2018","unstructured":"Gao F, Zhang J, Wang F, Xin X, Sha D. Cyclosporin A-related cerebral venous sinus thrombosis: a case report. Medicine (Baltimore). 2018, 97:10.1097\/MD.0000000000011642","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126441","article-title":"Real-world effectiveness and safety of eltrombopag in patients with aplastic anemia: a Chinese nationwide survey","volume":"134","author":"Yang BH","year":"2019","unstructured":"Yang BH, Chang H, Wu B, at al.. Real-world effectiveness and safety of eltrombopag in patients with aplastic anemia: a Chinese nationwide survey. Blood. 2019, 134:10.1182\/blood-2019-126441","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V82.4.1192.1192","article-title":"Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria","volume":"82","author":"Wiedmer T","year":"1993","unstructured":"Wiedmer T, Hall SE, Ortel TL, et al.. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood. 1993, 82:1192-6.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08366.x","article-title":"The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria","volume":"89","author":"R\u00f8nne E","year":"1995","unstructured":"R\u00f8nne E, Pappot H, Gr\u00f8ndahl-Hansen J, H\u00f8yer-Hansen G, Plesner T, Hansen NE, Dan\u00f8 K. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1995, 89:576-81. 10.1111\/j.1365-2141.1995.tb08366.x","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-08-0530","article-title":"Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial","volume":"105","author":"Spiel AO","year":"2011","unstructured":"Spiel AO, Bartko J, Schwameis M, et al.. Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost. 2011, 105:655-62. 10.1160\/TH10-08-0530","journal-title":"Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244808-aplastic-anemia-with-thrombosis-following-the-administration-of-immunosuppressant-and-thrombopoietin-receptor-agonist-tpo-ra","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T22:38:31Z","timestamp":1716763111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244808-aplastic-anemia-with-thrombosis-following-the-administration-of-immunosuppressant-and-thrombopoietin-receptor-agonist-tpo-ra"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.61135","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,26]]}}}